Unfortunately, despite increasingly active drugs targeting HER2 pathway, HER2 positive breast cancer remains incurable, although with new therapies, it may convert to a chronic disease at least in some patient subpopulations. The gene discussed is ERBB2; the disease is breast carcinoma.